BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17966105)

  • 1. [The insufficiency of low molecular weight heparin (LMWH) prophylaxis in patients with hereditary antithrombin (AT) deficiency].
    Dybowska M; Kuca P; Gralec R; Burakowski J; Tomkowski WZ
    Pneumonol Alergol Pol; 2007; 75(3):278-82. PubMed ID: 17966105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inefficacy of enoxaparin prophylaxis in a patient with congenital antithrombin deficiency.
    Tomkowski WZ; Dybowska M; Kuca P; Gralec R; Burakowski J
    Clin Appl Thromb Hemost; 2009; 15(2):241. PubMed ID: 19357104
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin for deep vein thrombosis in glioma patients.
    Schmidt F; Faul C; Dichgans J; Weller M
    J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perioperative management for transurethral resection of bladder tumor (TUR-Bt) associated with congenital antithrombin III deficiency].
    Mizuno J; Kato S; Namai S; Komiya Y; Kuwana Y; Morita S
    Masui; 2009 Dec; 58(12):1524-7. PubMed ID: 20055199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH).
    Holzheimer RG
    Eur J Med Res; 2004 Mar; 9(3):150-70. PubMed ID: 15096326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discharge of patients with venous thromboembolism: implications regarding therapy.
    Stein PD; Hull RD; Matta F; Yaekoub AY
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ambulatory treatment of an acute pulmonary artery embolism in fresh thigh vein thrombosis using low-molecular-weight heparin].
    Bauersachs RM; Lindhoff-Last E; Ehrly AM
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1485-8. PubMed ID: 10629667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep vein thrombosis and pulmonary embolism in the perioperative patient.
    Muntz JE
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1045-52. PubMed ID: 11484304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD
    Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2.
    Minshall CT; Eriksson EA; Leon SM; Doben AR; McKinzie BP; Fakhry SM
    J Trauma; 2011 Aug; 71(2):396-9; discussion 399-400. PubMed ID: 21825943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.